美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

三倍做多標普生物-Direxion

261.30

-4.7000-1.77%

盤後：261.300.00000.00%19:58 EDT

成交量：22.74萬

成交額：6,097.03萬

市值：4.90億

市盈率：- -

高：278.96

開：273.29

低：261.30

收：266.00

52周最高：341.93

52周最低：74.95

股本：187.45萬

流通股本：187.45萬

量比：0.94

換手率：12.13%

股息：1.00

股息率：0.38%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

醫療板塊市場快訊：行業動態一覽

石藥創新：控股子公司藥物獲美國FDA快速通道資格

巴克萊(BCS.US)任命Ramin Naji為亞太區醫療健康與房地產業務主管

百濟神州：美國FDA批准百澤安®聯合方案用於HER2陽性胃食管腺癌一線治療

能獨立抽血的機器人獲FDA授權

醫療健康板塊市場綜述：市場快訊

美國食品藥品監督管理局（FDA）向雅培旗下雅培糖尿病護理公司授予Libre Duo 10天雙參數葡萄糖‑酮體連續監測系統

美國衞生部計劃為FDA增設科技領域副專員與藥品領域副專員崗位。

FDA批准首款温性自身免疫性溶血性貧血藥物Imaavy。

強生公司（JNJ）Imaavy獲FDA標籤擴展用於治療温性自身免疫溶血性貧血

強生：IMAAVY獲FDA批准用於治療罕見血液疾病

REGENXBIO股價盤前下跌25%，因美國FDA暫停該公司針對亨特綜合徵的基因療法臨床試驗。

據CNBC，聯合包裹(UPS.US)將向國際業務、醫療保健和供應鏈業務投資20億美元。

據CNBC：聯合包裹(UPS.US)將向國際業務、醫療保健和供應鏈業務投資20億美元。

寶濟藥業-B(02659)：KJ015注射液(抗HER2雙特異性抗體皮下製劑)臨床試驗申請獲得美國FDA許可

醫療保健板塊動態：市場快訊

天津最新職工平均工資+福利待遇標準公布！

醫療保健板塊市場快訊：Moderna股價波動引關注，多股走勢分化

醫療保健板塊市場動態匯總

Hyperfine 宣佈其 Next Optive AI 軟件獲得美國 FDA 批准。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/LABU/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多標普生物-Direxion","latestPrice":261.3,"timestamp":1789156800000,"preClose":266,"halted":0,"volume":227375,"hourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.017669172932330786,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"未開盤","change":-4.7,"latestTime":"09-11 16:00:00 EDT","open":273.29,"high":278.9613,"low":261.3,"amount":60970299.293749996,"amplitude":0.066396,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":261.603,"aum":516531253.77,"dividendRate":0.003844,"bidAskSpread":0.003144,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9397711565267511,"impliedVol":0.8728,"impliedVolPercentile":0.3227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9397711565267511,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.066396,"preClose":266,"low":261.3,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":261.3,"eps":0,"divideRate":0.003844,"volume":227375,"delay":0,"ttmEps":0,"open":273.29,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1159893233","title":"醫療板塊市場快訊：行業動態一覽","url":"https://stock-news.laohu8.com/highlight/detail?id=1159893233","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159893233?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 16:25","pubTimestamp":1787732717,"startTime":"0","endTime":"0","summary":"0743 GMT——花旗研究在药明合联公布上半年业绩后，基于其强劲的增长可见性，继续维持对该股的看涨立场。分析师指出，这家医疗保健服务公司的管理层重申了2026年指引，预计2025年至2030年间收入复合年增长率将达30%-35%，同时提及包括里程碑费用在内的总积压订单同比增长了62%。该行将目标价由此前的73.00港元上调至93.00港元，并维持买入评级。该股目前下跌3.6%，报77.30港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4581","XLV","XBI","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662956217","title":"石藥創新：控股子公司藥物獲美國FDA快速通道資格","url":"https://stock-news.laohu8.com/highlight/detail?id=2662956217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662956217?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 16:00","pubTimestamp":1787731255,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662767102","title":"巴克萊(BCS.US)任命Ramin Naji為亞太區醫療健康與房地產業務主管","url":"https://stock-news.laohu8.com/highlight/detail?id=2662767102","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662767102?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 13:39","pubTimestamp":1787722750,"startTime":"0","endTime":"0","summary":"据悉，Ramin Naji将常驻香港，负责领导巴克莱在亚太地区的医疗健康及房地产板块业务，重点推动客户拓展、交易发起及执行。在汇报关系方面，Ramin Naji将在区域层面向巴克莱亚太区投资银行业务主管Avinash Thakur汇报，在职能层面则向全球医疗健康与地产业务集团主管Richard Landgarten汇报。加盟巴克莱前，Ramin Naji曾在德意志银行担任董事总经理及亚太区医疗健康业务主管。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159760","BK4588","REET","09979","BK4550","BK4581","LABU","XBI","BK1148","BK4207","IXJ","XLV","BK4521","BCS","BK4585","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662576689","title":"百濟神州：美國FDA批准百澤安®聯合方案用於HER2陽性胃食管腺癌一線治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2662576689","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662576689?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 09:15","pubTimestamp":1787706938,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4526","BK4585","BK4588","ONC","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662768698","title":"能獨立抽血的機器人獲FDA授權","url":"https://stock-news.laohu8.com/highlight/detail?id=2662768698","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662768698?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 07:08","pubTimestamp":1787699317,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ROBO","KOMP","LABU","PBOT","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127147911","title":"醫療健康板塊市場綜述：市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1127147911","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127147911?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 04:52","pubTimestamp":1787691172,"startTime":"0","endTime":"0","summary":"覆盖医疗健康领域的最新市场快讯。本资讯仅通过道琼斯通讯社于美东时间4:20、12:20及16:50独家发布。分析师同时警告，市场对此反应热烈，可能源于部分交易者误将该疫苗视作预防性疗法。Moderna股价当日大涨14%，报收158.10美元，在过去一个月内市值已近乎翻了三倍。该机构将Insmed的目标价从192美元上调至195美元，理由是该公司治疗非囊性纤维化支气管扩张症的Brinsupri疗法已获日本批准。Insmed股价当日收跌1.4%，报123.98美元，今年以来已累计下跌29%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4581","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662545751","title":"美國食品藥品監督管理局（FDA）向雅培旗下雅培糖尿病護理公司授予Libre Duo 10天雙參數葡萄糖‑酮體連續監測系統","url":"https://stock-news.laohu8.com/highlight/detail?id=2662545751","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662545751?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 02:33","pubTimestamp":1787682799,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0211331839.USD","LU1914381329.SGD","LU0266013472.USD","LU0170899867.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU1989763690.USD","LU0432979614.USD","LU2324357040.USD","BK4533","BK4581","SGXZ23171101.USD","LU2211815571.USD","LU1721429402.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","BK4566","BK4568","LU0114720955.EUR","LU1023059063.AUD","IE00BFTCPJ56.SGD","IHI","LU1691799644.USD","LU0882574055.USD","ABT","IE00B4R5TH58.HKD","SG9999004303.SGD","LU0058720904.USD","LU1989763427.SGD","IE00B2B36J28.USD","PJP","SGXZ41872573.SGD","BK4592","SG9999002224.SGD","BK4504","LU0234572021.USD","LU2089984988.USD","LU2468319806.SGD","BK4082","TMED","BK4585","LU1057294990.SGD","LU1721429741.USD","IE0002141913.USD","BK4588","LABU","LU0289739699.SGD","LU0070302665.USD","LU1061106388.HKD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662875609","title":"美國衞生部計劃為FDA增設科技領域副專員與藥品領域副專員崗位。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662875609","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662875609?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 01:03","pubTimestamp":1787677400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662823753","title":"FDA批准首款温性自身免疫性溶血性貧血藥物Imaavy。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662823753","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662823753?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 22:36","pubTimestamp":1787668576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073902","title":"強生公司（JNJ）Imaavy獲FDA標籤 擴展用於治療温性自身免疫溶血性貧血","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073902","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662073902?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 19:17","pubTimestamp":1787656672,"startTime":"0","endTime":"0","summary":"FDA已于今年4月授予Imaavy该项适应症的优先审评资格，本次获批后Imaavy有望成为美国市场首款针对wAIHA的治疗药物。据相关统计，wAIHA发病率约为八千分之一，发病机理为机体自身抗体破坏红细胞，进而引发贫血症状。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305283","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561909.HKD","LU0162691827.USD","IE00BZ1G4Q59.USD","IE00BBT3K403.USD","IE00BFTCPJ56.SGD","XLV","LU2456880835.USD","JDOC","RXL","IXJ","LU1221951046.USD","VHT","BMED","LU0345769631.USD","LU0234572021.USD","LU0820561818.USD","LU1629891620.HKD","FHLC","LU2756315664.SGD","IHE","TRUH","LU1914381329.SGD","FTXH","IYH","LU0795875169.SGD","BK4504","LU1585245621.USD","SG9999001176.SGD","IE000SO60NU8.SGD","IE00BJJMRZ35.SGD","MEDX","IE00BN8TJ469.HKD","LU0964807845.USD","BK4007","IE00B2B36J28.USD","IE00B19Z3B42.SGD","GDOC","LU2505996681.GBP","LU2347655156.SGD","BK4534","IE00BLSP4452.SGD","LU2430703251.USD","LABU","LU0210536198.USD","PJP","LU2750360997.AUD","JNJ","LU0787776722.HKD","LU2602419157.SGD","IE00B3PB1722.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662204777","title":"強生：IMAAVY獲FDA批准用於治療罕見血液疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2662204777","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662204777?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 08:18","pubTimestamp":1787617106,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0466842654.USD","JDOC","BK4532","LU2487616109.SGD","RXL","XLV","LU2505996509.AUD","LU0640476718.USD","BK4533","FHLC","LABU","LU2129689514.USD","LU0820562030.AUD","IXJ","LU1989771016.USD","LU1228905540.USD","LU2468319806.SGD","PJP","BK4588","IE000SO60NU8.SGD","LU1718418525.SGD","IE0034235303.USD","LU1629891620.HKD","LU1196500208.SGD","TRUH","FTXH","LU1066053197.SGD","IE0002270589.USD","BK4568","LU0320765646.SGD","LU0985320562.USD","LU2403377893.USD","IHE","LU0072461881.USD","VHT","LU2896262040.SGD","IYH","LU1267930813.SGD","JNJ","SGXZ57979304.SGD","GDOC","LU1674673691.USD","IE0009355771.USD","BK4592","LU1228905037.USD","IE00BJT1NW94.SGD","LU0203345920.USD","SG9999001176.SGD","BMED","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661759472","title":"REGENXBIO股價盤前下跌25%，因美國FDA暫停該公司針對亨特綜合徵的基因療法臨床試驗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661759472","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661759472?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:42","pubTimestamp":1787571759,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NITE","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273978","title":"據CNBC，聯合包裹(UPS.US)將向國際業務、醫療保健和供應鏈業務投資20億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273978","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273978?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:08","pubTimestamp":1787569727,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BFSS8Q28.SGD","LU0070302665.USD","IE00B19Z3581.USD","XLV","LU1430594728.SGD","LABU","IYT","CGVV","IE00B7SZLL34.SGD","LU1267930227.SGD","LU0128525689.USD","LU0496365809.HKD","BK4588","IE00BJJMRX11.SGD","BK4550","IE0004445015.USD","IE0002270589.USD","DOCK","LU1894683264.USD","LU2133065610.SGD","UPSG","NOBL","LU0061475181.USD","LU0052756011.USD","LU0320765646.SGD","BK4581","SUPL","LU1894683348.USD","LU0976567544.SGD","LU0149725797.USD","BK4131","VHT","BK4559","IE00B7KXQ091.USD","BK4585","UPS","LU0211326755.USD","LU1585245621.USD","LU2237438978.USD","XBI","BK4532","IE00BJJMRY28.SGD","HULL","LU1162221912.USD","LU0310800965.SGD","IE00B19Z3B42.SGD","LU0320765489.SGD","IE00BFSS7M15.SGD","LU0211331839.USD","SHPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661739272","title":"據CNBC：聯合包裹(UPS.US)將向國際業務、醫療保健和供應鏈業務投資20億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661739272","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661739272?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:07","pubTimestamp":1787569640,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0149725797.USD","LU2133065610.SGD","UPS","LU0976567544.SGD","IE00B7SZLL34.SGD","BK4131","IE0002270589.USD","IE00B19Z3B42.SGD","LU0052756011.USD","LU2237438978.USD","BK4532","IYT","LU0211326839.USD","LU0208291251.USD","LU1074936037.SGD","LU1430594728.SGD","LU0128525689.USD","SHPP","BK4534","LU1585245621.USD","IE00B19Z3581.USD","UPSG","XBI","LU0061475181.USD","IE00BFSS7M15.SGD","IE00BJJMRY28.SGD","BK4559","LU0310800965.SGD","SUPL","IE0004445015.USD","HULL","IE00BJJMRX11.SGD","LU0211326755.USD","LU1267930227.SGD","NOBL","LU0496365809.HKD","BK4550","LU1894683348.USD","BK4585","LU1162221912.USD","XLV","VHT","BK4588","IE00B7KXQ091.USD","LABU","CGVV","LU0070302665.USD","IE00BFSS8Q28.SGD","LU0320765489.SGD","DOCK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661095227","title":"寶濟藥業-B(02659)：KJ015注射液(抗HER2雙特異性抗體皮下製劑)臨床試驗申請獲得美國FDA許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2661095227","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661095227?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:02","pubTimestamp":1787565773,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宝济药业-B 发布公告，于2026年8月21日，本公司自主研发的KJ015注射液的新药临床试验申请获得美国食品药品监督管理局批准，获准在美国开展临床试验。本公司的临床前研究显示，KJ015相较于传统抗HER2单克隆抗体组合，在临床前阶段的整体疗效有所增强。本公司正内部开发KJ015，并拥有开发及商业化KJ015的全球权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","BMED","BK1161","BK4585","IBBQ","PSYK","02659","IBBJ","MDTX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110499199","title":"醫療保健板塊動態：市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1110499199","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110499199?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 00:25","pubTimestamp":1787329551,"startTime":"0","endTime":"0","summary":"聚焦医疗保健领域的最新市场快讯，独家发布于道琼斯通讯社，更新时段为美国东部时间凌晨4:20、中午12:20及下午4:50。美国东部时间凌晨5:40——与加密货币挂钩的美股在盘前交易中延续涨势，比特币与以太坊的强劲攀升成为主要推手。她指出，Zydus Lifesciences在获得美国食品药品监督管理局批准后，即可推出其仿制吲哚菁绿产品。与此同时，Provepharm已率先在英国市场推出其“Zyogreen”产品，并将目光投向美国市场以寻求进一步的地域扩张。该股应声下挫7.4%，报0.69美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1282649810.SGD","SGXZ51708014.SGD","IE00BGHQDM52.EUR","BK6516","LU0675040207.SGD","SG9999014484.SGD","SG9999002406.SGD","LU0831093199.SGD","LU2238330802.EUR","LU2506951875.HKD","LU2506952170.USD","LU0488056044.USD","LU2257852520.SGD","LU0251144936.SGD","LU1282649141.HKD","SG9999008742.SGD","LU0898667661.SGD","LU1497734951.SGD","SGXZ91733576.SGD","LU0169518387.USD","BKCH","LU0084288322.USD","SG9999013486.USD","IE00BVYPNP33.GBP","LU0672654166.SGD","SG9999011175.SGD","SG9999014302.SGD","SG9999003800.SGD","LU1282649067.USD","BK6523","LU0971096721.USD","LU0577902611.USD","SG9999001846.SGD","SGXZ27511609.SGD","SG9999000459.SGD","LU0823413587.USD","SG9999004220.SGD","LU0648948544.HKD","CRPT","GDLC","LU0192582467.USD","LU0823039010.USD","LU0886674414.USD","LU0577902538.SGD","XLV","SG9999013353.USD","LU0955669360.SGD","SG9999001135.SGD","LU0762540952.USD","D05.SI","LU0588545490.SGD","LFGY","LU0384037296.USD","LU1839390173.USD","SG9999002679.SGD","LU0261945553.USD","SG9999013460.SGD","BK6112","LU1634259557.SGD","SG9999016042.SGD","SG9999004360.SGD","SG9999001127.SGD","LU0205439572.USD","LU2152927971.USD","LU1770036033.HKD","BK4588","LU0532188223.SGD","LU0043850808.USD","LU1956131251.USD","LU0061477393.USD","LU0048597586.USD","LU0345776255.USD","LU0878004406.USD","SGXZ70427877.SGD","LU2506952097.USD","LU2237957811.SGD","LU0577902371.SGD","LU0865486749.SGD","IE0031814969.USD","SG9999001903.USD","SG9999014492.USD","LU1504937902.USD","SGXZ16066938.SGD","LU0823417653.USD","SGXZ58947870.SGD","LU0823413660.USD","LU3227948356.SGD","SG9999002604.SGD","LU1522347837.USD","LU2237957902.USD","SG9999013478.USD","SGXZ43160589.SGD","LU1497733631.SGD","LU0315178854.USD","SG9999009443.AUD","LU0029875118.USD","LU0128522157.USD","IE0003895053.USD","LU0588545904.SGD","LU0211331839.USD","LU0048573645.USD","SG9999000343.SGD","NCIQ","LU0955648018.USD","LU0188438112.USD","SG9999005177.SGD","LU0950375773.USD","IE00BVYPNQ40.USD","LU0882747503.HKD","LU0557290698.USD","LU0235996351.USD","SG9999000475.SGD","LU0823417737.USD","DAPP","LU1497733557.USD","LU0823397103.USD","LU0251143029.SGD","LU0441851309.USD","LU0096374516.USD","LU0441854154.USD","SG9999002562.SGD","LU0011963245.USD","LU0165289439.USD","IE00BKZH1Z71.USD","LU0878005551.USD","SG9999003826.SGD","LU0577902298.EUR","LU1211504680.USD","XBI","BITQ","LU0210637038.USD","LU1363072403.SGD","LU0823397285.USD","LU0577902454.USD","LU0345775950.USD","SGXZ24219693.SGD","LU2506951958.HKD","LU0630378429.USD","LU0831103253.SGD","SG9999007991.SGD","BK4585","LU0955623706.USD","SG9999006266.SGD","LU0823038988.USD","LU1634259391.SGD","SG9999002620.SGD","LU0543330483.HKD","LU0261947096.USD","LU0873338254.USD","STCE","SG9999002414.USD","BITW","LU0588545730.USD","BK4581","LABU","LU0320764755.SGD","LU0326948709.USD","LU1130305938.SGD","LU0737861269.HKD","SG9999001226.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661578261","title":"天津最新職工平均工資+福利待遇標準公布！","url":"https://stock-news.laohu8.com/highlight/detail?id=2661578261","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661578261?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 17:43","pubTimestamp":1787305380,"startTime":"0","endTime":"0","summary":"答：2025年全市职工平均工资发布后，同步调整的职工有关保险、工资、福利待遇仍按历年政策，从2026年1月1日起执行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-21/doc-iniparar1550862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","BK4581","XBI","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103038072","title":"醫療保健板塊市場快訊：Moderna股價波動引關注，多股走勢分化","url":"https://stock-news.laohu8.com/highlight/detail?id=1103038072","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103038072?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 04:53","pubTimestamp":1787259191,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场快讯，涵盖多家重要企业动态。Moderna股价周三飙升176%，但瑞银分析师认为，这一涨幅可能是华尔街对Moderna与默克联合开发的mRNA黑色素瘤疫苗强劲结果的过度反应。他们维持Moderna每股150美元的目标价，尽管该股周三收于174美元。在周三市值翻倍有余后，Moderna盘前回落12%。Ebos 2026财年业绩引人注目，部分原因在于其未包含的内容。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XLV","BK4588","XBI","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142647815","title":"醫療保健板塊市場動態匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1142647815","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142647815?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 00:22","pubTimestamp":1787242968,"startTime":"0","endTime":"0","summary":"美东时间0824——UBS分析师指出，Moderna周三股价暴涨176%或许正是华尔街对Moderna与默克联合开发的mRNA黑色素瘤疫苗优异临床数据做出的过度反应。Moderna市值随之飙升至700亿美元；即便给予其新冠疫苗业务一个相对保守的估值，这仍意味着仅该款癌症疫苗一项就被赋予了约600亿美元的估值，对应年销售额需达200亿美元。分析师认为，这一预期可能过于乐观，不切实际。周三收盘价为174美元，UBS维持其150美元的目标价不变。盘前交易中，该股下跌10%，报156.30美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","XBI","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848552","title":"Hyperfine 宣佈其 Next Optive AI 軟件獲得美國 FDA 批准。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848552","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848552?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 20:15","pubTimestamp":1787228137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","QTOC","HYPR","BK4585","CHAT","LABU","AGIX","BK4082","VGT","ARTY","AIPO","VTHR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}